A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Linagliptin Impurity 107 - Request Quote

Picture of Linagliptin Impurity 107

Linagliptin Impurity 107

SZ CAT No:SZ-L024165
CAS No
NA
Mol.F.
C26H28N8O2
Mol.Wt.
484.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Linagliptin Impurity 107 is chemically 7-(But-2-yn-1-yl)-3-methyl-8-(3-(methyleneamino)piperidin-1-yl)-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione. Linagliptin Impurity 107 is supplied with detailed characterization data compliant with regulatory guideline. Linagliptin Impurity 107 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linagliptin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Linagliptin Impurity 107

Purchase Linagliptin Impurity 107

Linagliptin Impurity 107 suppliers

Linagliptin Impurity 107 manufacturers

Linagliptin Impurity 107 price

Order Linagliptin Impurity 107

Enquire Linagliptin Impurity 107

Linagliptin Impurity 107 cost

Linagliptin Impurity 107 Supplier

Linagliptin Impurity 107 Distributor

Linagliptin Impurity 107 for Method Validation

Linagliptin Reference Standard

Linagliptin Impurity 107 for ANDA Filing

Linagliptin Impurity 107 for Forced Degradation Studies

Linagliptin Impurity 107 Identification Standards

Linagliptin Impurity 107 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,